ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
-1.03%
Bitcoin
62,974.07
6.52%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. DiaMedica Therapeutics Inc (DMAC)

  7. DiaMedica Therapeutics Inc (DMAC) Noticias

DMAC

DiaMedica Therapeutics (DMAC)

DiaMedica Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DMAC
FechaHoraFuenteTítuloSímboloCompañía
02/05/202407:55Business WireDiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024NASDAQ:DMACDiaMedica Therapeutics Inc
17/04/202415:08Business WireDiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic StrokeNASDAQ:DMACDiaMedica Therapeutics Inc
19/03/202415:15Business WireDiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
29/01/202415:13Business WireDiaMedica Therapeutics Announces Poster Presentation at International Stroke ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
23/01/202415:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
23/01/202415:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMACDiaMedica Therapeutics Inc
22/01/202407:23Business WireDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical OfficerNASDAQ:DMACDiaMedica Therapeutics Inc
13/11/202315:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DMACDiaMedica Therapeutics Inc
13/11/202315:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMACDiaMedica Therapeutics Inc
13/11/202315:28Business WireDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
09/11/202307:25Business WireDiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
06/11/202307:23Business WireDiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
12/09/202307:13Business WireDiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology OfficerNASDAQ:DMACDiaMedica Therapeutics Inc
06/09/202307:35Business WireDiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
14/08/202315:13Business WireDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
08/08/202307:32Business WireDiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
18/07/202307:30Business WireDiaMedica Therapeutics to Attend the American Academy of Neurology Summer ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
10/07/202315:16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DMACDiaMedica Therapeutics Inc
09/07/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DMACDiaMedica Therapeutics Inc
30/06/202315:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DMACDiaMedica Therapeutics Inc
27/06/202315:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
27/06/202315:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DMACDiaMedica Therapeutics Inc
26/06/202307:30Business WireDiaMedica Therapeutics Announces Closing of $37.5 Million Private PlacementNASDAQ:DMACDiaMedica Therapeutics Inc
23/06/202316:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DMACDiaMedica Therapeutics Inc
21/06/202307:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
21/06/202307:39Business WireDiaMedica Therapeutics Announces $37.5 Million Private PlacementNASDAQ:DMACDiaMedica Therapeutics Inc
21/06/202307:15Business WireDiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic StrokeNASDAQ:DMACDiaMedica Therapeutics Inc
30/05/202307:29Business WireDiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of DirectorsNASDAQ:DMACDiaMedica Therapeutics Inc
15/05/202315:28Business WireDiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
08/05/202307:50Business WireDiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023NASDAQ:DMACDiaMedica Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DMAC

Su Consulta Reciente

AMEX
SPY
SPDR S&P 500
USOTC
ADDYY
Adidas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
USOTC
BNPQY
BNP Paribas (QX)
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
USOTC
RHHBY
Roche (QX)
COIN
BTCUSD
Bitcoin
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados